[Brolucizumab (neovascular age-related macular degeneration) – Addendum to Project A23-101]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018012151
German
Original Title: Brolucizumab (neovaskuläre altersabhängige Makuladegeneration) - Addendum zum Projekt A23-101
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/a24-31.html
Year Published: 2024
URL for published report: https://www.iqwig.de/download/a24-31_brolucizumab_addendum-zum-projekt-a23-101_v1-0.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
DOI: https://doi.org/10.60584/A24-31
MeSH Terms
  • Angiogenesis Inhibitors
  • Macular Degeneration
  • Intravitreal Injections
  • Antibodies, Monoclonal, Humanized
  • Wet Macular Degeneration
Keywords
  • Brolucizumab
  • Macular Degeneration
  • Benefit Assessment
  • NCT04005352
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.